| scholarly article | Q13442814 |
| P50 | author | Peter Vermathen | Q51701065 |
| P2093 | author name string | Harriet C Thoeny | |
| Urs E Studer | |||
| Lauren J Bains | |||
| Johannes M Froehlich | |||
| Achim Fleischmann | |||
| Maria Triantafyllou | |||
| Juerg Huesler | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lymph node | Q170758 |
| P304 | page(s) | 125-135 | |
| P577 | publication date | 2014-06-02 | |
| P1433 | published in | Radiology | Q3285690 |
| P1476 | title | Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging | |
| P478 | volume | 273 |
| Q93228454 | A glance at imaging bladder cancer |
| Q38823661 | A urologist's perspective on prostate cancer imaging: past, present, and future |
| Q58789119 | Accelerated diffusion-weighted imaging for lymph node assessment in the pelvis applying simultaneous multislice acquisition: A healthy volunteer study |
| Q47159831 | Biparametric MRI of the prostate |
| Q50128064 | Bladder cancer local staging: multiparametric MRI performance following transurethral resection |
| Q49686666 | Computed tomography and magnetic resonance imaging evaluation of pelvic lymph node metastasis in bladder cancer |
| Q38769553 | Current Status of Lymph Node Imaging in Bladder and Prostate Cancer |
| Q92466044 | Defining the incremental value of 3D T2-weighted imaging in the assessment of prostate cancer extracapsular extension |
| Q36378406 | Differentiating metastatic from nonmetastatic lymph nodes in cervical cancer patients using monoexponential, biexponential, and stretched exponential diffusion-weighted MR imaging |
| Q90383089 | Diffusion-Weighted Genitourinary Imaging |
| Q59137130 | Diffusion-weighted imaging (DWI) in lymph node staging for prostate cancer |
| Q58283606 | Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology |
| Q59130946 | Evaluation of lymph node status in patients with urothelial carcinoma-still in search of the perfect imaging modality: a systematic review |
| Q47829959 | Functional and Targeted Lymph Node Imaging in Prostate Cancer: Current Status and Future Challenges. |
| Q38611187 | Imaging and evaluation of patients with high-risk prostate cancer. |
| Q89823517 | Imaging for Metastasis in Prostate Cancer: A Review of the Literature |
| Q57105949 | Imaging of distant metastases of prostate cancer |
| Q30244033 | Imaging on nodal staging of prostate cancer |
| Q52653486 | Imaging the High-risk Prostate Cancer Patient: Current and Future Approaches to Staging. |
| Q87855568 | Indication to pelvic lymph nodes dissection for prostate cancer: the role of multiparametric magnetic resonance imaging when the risk of lymph nodes invasion according to Briganti updated nomogram is <5 |
| Q93182676 | Local failure is a dominant mode of recurrence in locally advanced and clinical node positive prostate cancer patients treated with combined pelvic IMRT and androgen deprivation therapy |
| Q47157403 | Lymph node imaging in initial staging of prostate cancer: An overview and update |
| Q38379159 | Lymph node staging in prostate cancer. |
| Q55000240 | MRI and 11C Acetate PET/CT for Prediction of Regional Lymph Node Metastasis in Newly Diagnosed Prostate Cancer. |
| Q26751352 | MRI of endometrium cancer - how we do it |
| Q89769322 | MRI-guided pelvic lymph node biopsy via transrectal approach in prostate cancer |
| Q38636446 | Magnetic resonance imaging for prostate cancer before radical and salvage radiotherapy: What radiation oncologists need to know |
| Q35395432 | Magnetic resonance sentinel lymph node imaging of the prostate with gadofosveset trisodium-albumin: preliminary results in a canine model |
| Q57173790 | Multiparametric MR imaging of the Prostate: Interpretation Including Prostate Imaging Reporting and Data System Version 2 |
| Q64993061 | Multiparametric MRI - local staging of prostate cancer and beyond. |
| Q64902379 | Multiparametric whole-body 3.0-T MRI in newly diagnosed intermediate- and high-risk prostate cancer: diagnostic accuracy and interobserver agreement for nodal and metastatic staging. |
| Q88682227 | Optimizing the diagnosis of pelvic lymph node metastasis in bladder cancer using computed tomography and magnetic resonance imaging |
| Q57780524 | PET/MRI and prostate cancer |
| Q29037908 | PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2 |
| Q92886274 | PSMA PET for primary lymph node staging of intermediate and high-risk prostate cancer: an expedited systematic review |
| Q36109230 | PSMA PET/CT with Glu-urea-Lys-(Ahx)-[⁶⁸Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer |
| Q41021179 | Pelvic MRI findings in relapsed prostate cancer after radical prostatectomy |
| Q30968069 | Pitfalls and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in the Diagnosis of Urinary Bladder Cancer |
| Q47261973 | Preoperative multiparametric MRI of the prostate for the prediction of lymph node metastases in prostate cancer patients treated with extended pelvic lymph node dissection |
| Q26749289 | Prostate MRI based on PI-RADS version 2: how we review and report |
| Q38796980 | Prostate cancer risk stratification with magnetic resonance imaging |
| Q53011375 | Prostate cancer: Can imaging accurately diagnose lymph node involvement? |
| Q59130955 | Sentinel lymph node imaging in urologic oncology |
| Q99571133 | The Role of Imaging in Bladder Cancer Diagnosis and Staging |
| Q92541870 | The Role of Radical Prostatectomy and Lymph Node Dissection in Clinically Node Positive Patients |
| Q31161802 | The use of diffusion weighted imaging to evaluate pathology outside the brain parenchyma in neuroimaging studies |
| Q58562134 | Ultra-small superparamagnetic iron oxide contrast agents for lymph node staging of high-risk prostate cancer |
| Q39350373 | Updates for the radiologist in non-muscle-invasive, muscle-invasive, and metastatic bladder cancer. |
| Q35170100 | Utility of preoperative ferumoxtran-10 MRI to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN 6671/GOG 0233. |
| Q53098000 | Whole body MRI (WB-MRI) assessment of metastatic spread in prostate cancer: Therapeutic perspectives on targeted management of oligometastatic disease. |
| Q88769184 | [CCAFU french national guidelines 2016-2018 on bladder cancer] |
| Q104517664 | [French ccAFU guidelines - update 2020-2022: bladder cancer] |
| Q88550466 | [PI-RADS 2.0 for Prostate MRI] |
Search more.